Cronos Group Inc.

Healthcare

NASDAQ:CRON · NASDAQ Global Market

Market Cap $997.68M Beta 1.25 P/E (TTM) -488.3

$2.71 -0.56%

-$0.02 today

52W Low $1.84High $3.43

Vol 1.21M · Avg 1.51M

EPS (TTM) -$0.01Drug Manufacturers - Specialty & Generic

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+44.92%

Period High

$3.27

Period Low

$1.87

Latest

$2.71

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Nurix Therapeutics, Inc.

NASDAQ:NRIX

$1.49B

Rapport Therapeutics, Inc. Common Stock

NASDAQ:RAPP

$1.35B

IRadimed Corporation

NASDAQ:IRMD

$1.18B

Collegium Pharmaceutical, Inc.

NASDAQ:COLL

$1.08B

Xencor, Inc.

NASDAQ:XNCR

$937.15M

Pacira BioSciences, Inc.

NASDAQ:PCRX

$883.27M

Phathom Pharmaceuticals, Inc.

NASDAQ:PHAT

$855.06M

Amphastar Pharmaceuticals, Inc.

NASDAQ:AMPH

$839.09M

BridgeBio Oncology Therapeutics Inc.

NASDAQ:BBOT

$606.81M

Embecta Corp.

NASDAQ:EMBC

$184.19M

What is the latest CRON filing?

The latest filing shown is SD dated May 29, 2026.

How many recent filings does CRON have?

Intrinsic Alpha currently shows 20 recent filings for CRON.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.